Loading data...
Loading data...
Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | HIMS Hims & Hers Health, Inc. | ABBV AbbVie |
|---|---|---|
| Price | $27.99 +0.4% | $263.96 -0.0% |
| StockIQ Score | 52C- Moderate Risk: Medium | 59C Moderate Risk: High |
| Technical | 46D+ | 88A |
| Fundamental | 66B- | 57C |
| Growth | 54C- | 34F |
| Fair Value | 45D+ | 33F |
| News | 38F | 100A+ |
| Quality | 58C | 42D |
| Risk | 48D+ | 36F |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Hims & Hers (HIMS) scores higher than AbbVie (ABBV) on investor (49 vs 48), fundamental (66 vs 56), growth (54 vs 34) and valuation (45 vs 33) metrics. AbbVie leads in technical score, posting 42 compared with HIMS’s 16.